Daniel S. Sperling MD, DABR

Dr. Dan Sperling is a leader in the detection of prostate tumors through the use of image-guided technology. Dr. Sperling developed the 3T Multi-Parametric MRI – BlueLaser™ solutions. He specializes in Magnetic Resonance Imaging (MRI) which he uses for tumor detection, targeted biopsies (MRI-Guided Biopsy; prostate mapping, and treatment).

Dr. Sperling serves as Medical Director and Chief of Interventional Uroradiology at the Sperling Prostate Center in Florida and New York, as well as the Medical Director of its parent practice, the Sperling Medical Group.

Dr. Sperling is a member of the American Board of Radiology and licensed in Massachusetts, Florida, Maryland, New York and New Jersey. Additionally, he is certified by the Society of Uroradiology, American Society of Laser Medicine and is an American Board of Radiology Diplomate. He completed a fellowship in oncologic PET/CT and interventional body imaging at the Albert Einstein College of Medicine at Montefiore Medical Center in New York. He completed a second fellowship in nuclear radiology at the New York University School of Medicine at Northshore University Hospital.